Comparative Study of Efficacy between Cyclosporine and Alitretinoin in Patients with Chronic Hand Eczema
Dermatitis® · 2024
DOI: 10.1089/derm.2023.0113 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Dermatitis®, 2024. Verfasst von Jin Hyun Jang und 6 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, College of Medicine, Hanyang University, Seoul, Korea. Hauptthemen laut MEDLINE: Cyclosporine, Alitretinoin, Hand Dermatoses, Eczema. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Background
Systemic remedies such as cyclosporine, methotrexate, and retinoids are off-license treatment options that are considered for severe chronic hand eczema (CHE) that is resistant to first-line treatment.
Objectives
The objective of this study was to determine the optimal treatment of CHE patients, including those with atopic Dermatitis®, and to compare the efficacy between cyclosporine and alitretinoin.
Methods
This study was retrospective and included CHE patients who visited the Department of Dermatology at Hanyang University Seoul Hospital in Korea between March 2013 and February 2020.
Results
A total of 95 CHE patients was included in this study. In the cyclosporine treatment group, there were more patients with severe baseline Investigator Global Assessment (IGA) ( P = 0.033) and higher immunoglobulin E (IgE) level ( P = 0.019). The mean recurrence duration was 15.9 weeks in the alitretinoin group and 22.9 weeks in the cyclosporine group, the difference between which was not statistically significant. In a subgroup analysis according to treatment drug, only the low IgE group showed a better recurrence profile for alitretinoin treatment compared to cyclosporine treatment ( P = 0.039). When comparing the cumulative recurrence rate during the treatment period and subsequent follow-up periods, the cyclosporine group showed a greater incidence of recurrence than the alitretinoin group in all follow-up periods. The results of our study are consistent with the previously reported efficacy of alitretinoin. Despite the rapid response in the cyclosporine group, 12 weeks of CHE treatment with alitretinoin showed superior efficacy compared to cyclosporine treatment.
Conclusions
Both alitretinoin and cyclosporine groups showed efficacy in patients with CHE. Cyclosporine is an alternative treatment of CHE that is refractory to alitretinoin or relapses after its use, especially in the presence of atopic Dermatitis®.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Dermatology, College of Medicine, Hanyang University, Seoul, Korea.
- Department of Dermatology, Daejeon Eulji Medical Center, Eulji University College of Medicine, Daejeon, Korea.
ORCID-Profile: Jin Hyun Jang, Joo Yeon Ko
Zitieren
APA
Jang, J. H., Joh, H. C., Song, C. H., Kim, K. Y., Jue, M. S., Ro, Y. S., & Ko, J. Y. (2024). Comparative Study of Efficacy between Cyclosporine and Alitretinoin in Patients with Chronic Hand Eczema. Dermatitis®. https://doi.org/10.1089/derm.2023.0113
Vancouver
Jang JH, Joh HC, Song CH, Kim KY, Jue MS, Ro YS, et al. Comparative Study of Efficacy between Cyclosporine and Alitretinoin in Patients with Chronic Hand Eczema. Dermatitis®. 2024. doi:10.1089/derm.2023.0113
BibTeX
@article{Jang2024,
author = {Jang, Jin Hyun and Joh, Hae Chang and Song, Chang Hwa and Kim, Ki Yeon and Jue, Mihn Sook and Ro, Young Suck and Ko, Joo Yeon},
title = {Comparative Study of Efficacy between Cyclosporine and Alitretinoin in Patients with Chronic Hand Eczema},
journal = {Dermatitis®},
year = {2024},
doi = {10.1089/derm.2023.0113}
}
EUVIMED